Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure

被引:34
作者
van der Lee, Johanna H. [1 ]
Morton, Jonathan [2 ]
Adams, Heather R. [3 ]
Clarke, Lorne [4 ]
Ebbink, Berendine Johanne [5 ]
Escolar, Maria L. [6 ]
Giugliani, Roberto [7 ]
Harmatz, Paul [8 ]
Hogan, Melissa [9 ]
Jones, Simon [10 ]
Kearney, Shauna [11 ]
Muenzer, Joseph [12 ]
Rust, Stewart [13 ]
Semrud-Clikeman, Margaret [14 ]
Wijburg, Frits A. [15 ]
Yu, Zi-fan [16 ]
Janzen, Darren [17 ]
Shapiro, Elsa [14 ,18 ]
机构
[1] Acad Med Ctr, Emma Childrens Hosp, Pediat Clin Res Off, Amsterdam, Netherlands
[2] Comradis Ltd, Oxford, England
[3] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA
[4] Univ British Columbia, British Columbia Childrens Hosp, Res Inst, Vancouver, BC, Canada
[5] Erasmus MC Univ Med Ctr, Ctr Lysosomal & Metab Dis, Rotterdam, Netherlands
[6] Pittsburgh Sch Med, Dept Pediat, Pittsburgh, PA USA
[7] Med Genet Serv HCPA, Dept Genet UFRGS, Porto Alegre, RS, Brazil
[8] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA
[9] Saving Case & Friends, Thompsons Stn, TN USA
[10] St Marys Hosp, Manchester Ctr Genom Med, Willink Biochem Genet Unit, Manchester, Lancs, England
[11] Birmingham Childrens Hosp NHS Fdn Trust, Clin Paediat Psychol, Birmingham, W Midlands, England
[12] Univ North Carolina Chapel Hill, Dept Pediat, Chapel Hill, NC USA
[13] Royal Manchester Childrens Hosp, Paediat Psychosocial Dept, Manchester, Lancs, England
[14] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[15] Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands
[16] Stat Collaborat Inc, Washington, DC USA
[17] Oregon Hlth & Sci Univ, Inst Dev & Disabil, Portland, OR 97201 USA
[18] Shapiro Neuropsychol Consulting LLC, Portland, OR USA
关键词
Mucopolysaccharidoses; Cognitive; Adaptive behavior; Neurological; Clinical trial; Protocol; ENZYME REPLACEMENT THERAPY; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CLINICAL-PRACTICE PROTOCOL; LONG-TERM EFFICACY; HURLER-SYNDROME; NATURAL-HISTORY; FUNCTIONAL OUTCOMES; DISEASE PROGRESSION; STORAGE DISEASES;
D O I
10.1016/j.ymgme.2017.05.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The design and conduct of clinical studies to evaluate the effects of novel therapies on central nervous system manifestations in children with neuronopathic mucopolysaccharidoses is challenging. Owing to the rarity of these disorders, multinational studies are often needed to recruit enough patients to provide meaningful data and statistical power. This can make the consistent collection of reliable data across study sites difficult. To address these challenges, an International MPS Consensus Conference for Cognitive Endpoints was convened to discuss approaches for evaluating cognitive and adaptive function inpatients with mucopolysaccharidoses. The goal was to develop a consensus on best practice for the design and conduct of clinical studies investigating novel therapies for these conditions, with particular focus on the most appropriate outcome measures for cognitive function and adaptive behavior. The outcomes from the consensus panel discussion are reported here. (C) 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:70 / 79
页数:10
相关论文
共 89 条
  • [51] A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
    Muenzer, Joseph
    Wraith, James E.
    Beck, Michael
    Giugliani, Roberto
    Harmatz, Paul
    Eng, Christine M.
    Vellodi, Ashok
    Martin, Rick
    Ramaswami, Uma
    Gucsavas-Calikoglu, Muge
    Vijayaraghavan, Suresh
    Wendt, Suzanne
    Puga, Antonio
    Ulbrich, Brian
    Shinawi, Marwan
    Cleary, Maureen
    Piper, Diane
    Conway, Ann Marie
    Kimura, Alan
    [J]. GENETICS IN MEDICINE, 2006, 8 (08) : 465 - 473
  • [52] A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
    Muenzer, Joseph
    Hendriksz, Christian J.
    Fan, Zheng
    Vijayaraghavan, Suresh
    Perry, Victor
    Santra, Saikat
    Solanki, Guirish A.
    Mascelli, Mary Ann
    Pan, Luying
    Wang, Nan
    Sciarappa, Kenneth
    Barbier, Ann J.
    [J]. GENETICS IN MEDICINE, 2016, 18 (01) : 73 - 81
  • [53] The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus
    Muenzer, Joseph
    Bodamer, Olaf
    Burton, Barbara
    Clarke, Lorne
    Frenking, Gudrun Schulze
    Giugliani, Roberto
    Jones, Simon
    Munoz Rojas, Maria Veronica
    Scarpa, Maurizio
    Beck, Michael
    Harmatz, Paul
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (01) : 181 - 188
  • [54] Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
    Muenzer, Joseph
    Beck, Michael
    Eng, Christine M.
    Giugliani, Roberto
    Harmatz, Paul
    Martin, Rick
    Ramaswami, Uma
    Vellodi, Ashok
    Wraith, James E.
    Cleary, Maureen
    Gucsavas-Calikoglu, Muge
    Puga, Ana Cristina
    Shinawi, Marwan
    Ulbrich, Birgit
    Vijayaraghavan, Suresh
    Wendt, Susanne
    Conway, Anne Marie
    Rossi, Alexandra
    Whiteman, David A. H.
    Kimura, Alan
    [J]. GENETICS IN MEDICINE, 2011, 13 (02) : 95 - 101
  • [55] Mucopolysaccharidosis I: Management and Treatment Guidelines
    Muenzer, Joseph
    Wraith, James E.
    Clarke, Lorne A.
    [J]. PEDIATRICS, 2009, 123 (01) : 19 - 29
  • [56] Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia
    Mullen, CA
    Thompson, JN
    Richard, LA
    Chan, KW
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (10) : 1093 - 1097
  • [57] Mullen E., 1995, MULLEN SCALES EARLY, DOI DOI 10.3389/FPSYT.2016.00204
  • [58] MPS II: Adaptive Behavior of Patients and Impact on the Family System
    Needham, Mary
    Packman, Wendy
    Rappoport, Maxwell
    Quinn, Natasha
    Cordova, Matthew
    Macias, Sandra
    Morgan, Cynthia
    Packman, Seymour
    [J]. JOURNAL OF GENETIC COUNSELING, 2014, 23 (03) : 330 - 338
  • [59] Neufeld EF., 2001, The metabolic molecular basis of inherited disease, V8th ed., P3421, DOI DOI 10.1036/OMMBID.165
  • [60] Papadia F, 2011, EUR REV MED PHARMACO, V15, P253